CERO
CERo Therapeutics Holdings Inc

4,481
Mkt Cap
$924,804.00
Volume
1.64M
52W High
$26.99
52W Low
$0.0175
PE Ratio
0.00
CERO Fundamentals
Price
$0.0197
Prev Close
$0.0205
Open
$0.018
50D MA
$0.0308
Beta
3.98
Avg. Volume
609,617.10
EPS (Annual)
-$22.58
P/B
-0.04
Rev/Employee
$0.00
$6.58
Loading...
Loading...

About

CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in Oakland, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
8

Frequently Asked Questions

What is Market Cap of CERo Therapeutics Holdings Inc.?
What is the 52-week high for CERo Therapeutics Holdings Inc.?
What is the 52-week low for CERo Therapeutics Holdings Inc.?
What is CERo Therapeutics Holdings Inc. stock price today?
What was CERo Therapeutics Holdings Inc. stock price yesterday?
What is the Price-to-Book ratio of CERo Therapeutics Holdings Inc.?
What is the 50-day moving average of CERo Therapeutics Holdings Inc.?
How many employees does CERo Therapeutics Holdings Inc. have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available